Video: Sino Biological: the global leader in recombinant technology
Sino Biological is an international reagent supplier and service provider. The company specialises in recombinant protein production and antibody development.
List view / Grid view
Sino Biological is an international reagent supplier and service provider. The company specialises in recombinant protein production and antibody development.
Solutions to help you understand viral diseases and translate your research findings into better treatments and vaccines.
A National Science and Technology Council and Office for Science and Technology Strategy will be established to aid the UK's scientific industry.
Included in this ebook are articles on stem cell-derived liver organoids and pluripotent cell-derived endothelial cells.
A panel of SARS-CoV-2 reagents (e.g. antigens, antibodies, and kits) and influenza antigens have been developed to support the development of vaccines.
Scientists say COVID-19 may activate tuberculosis infection, but stem cell-mediated defence mechanisms could be targeted to develop vaccines.
Scientists have found differences in 206 genes between the GRCh38 (hg38) and GRCh37 (hg19) human reference genomes.
For the first time, scientists have found evidence that polymerase theta can write RNA segments back into DNA.
Researchers have shown that the SARS-CoV-2 PLpro cuts human proteins so could potentially cause a range of COVID-19 symptoms.
Researchers have created an X-ray scanning machine that shows the shape of an object and its molecular composition.
Complete solutions for neurological disease research and discovery - helping you to better understand diseases to improve patient outcomes.
Analysis of one million SARS-CoV-2 genome sequences has revealed a new variant named T478K, spreading mostly in Mexico.
We discuss how liquid handling automation supports drug discovery workflows & highlight opportunities to improve the efficiency and quality of these.
Scientists have created a RT-ddPCR assay to analyse both the non-coding and coding RNA regions of SARS-CoV-2.
Learn about a practical, high-throughput method for validating the target-specificity of antibodies for the application of western blot.